home / openregs / federal_register

federal_register: 2018-26855

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2018-26855 The “Deemed to be a License” Provision of the BPCI Act: Questions and Answers; Draft Guidance for Industry; Availability; Request for Comments on Preliminary List of Affected Applications Notice The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "The `Deemed to be a License' Provision of the BPCI Act: Questions and Answers." This draft guidance is intended to provide answers to common questions about FDA's interpretation of the statutory provision under which an application for a biological product approved under the Federal Food, Drug, and Cosmetic Act (FD&C Act) as of March 23, 2020, will be deemed to be a license for the biological product under the Public Health Service Act (PHS Act) on March 23, 2020. This guidance also describes FDA's compliance policy for the labeling of biological products that will be the subject of deemed biologics license applications (BLAs). This guidance is intended to facilitate planning for the March 23, 2020, transition date and provide further clarity regarding the Agency's interpretation of this statutory provision. FDA also invites comment on the preliminary list of approved new drug applications (NDAs) for biological products under the FD&C Act that will be deemed to be BLAs on the transition date. 2018-12-12 2018 12 https://www.federalregister.gov/documents/2018/12/12/2018-26855/the-deemed-to-be-a-license-provision-of-the-bpci-act-questions-and-answers-draft-guidance-for https://www.govinfo.gov/content/pkg/FR-2018-12-12/pdf/2018-26855.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "The `Deemed to be a License' Provision of the BPCI Act: Questions and Answers." This draft guidance is intended to provide...

Links from other tables

  • 2 rows from document_number in federal_register_agencies
  • 1 row from fr_document_number in fr_regs_crossref
Powered by Datasette · Queries took 1.91ms